All News #Library
Biotech
Next Steps for Roche`s High-Cost Obesity Pipeline
19 Sep 2025 //
FIERCE BIOTECH
Roche Axes Carmot Obesity Asset, 3 Cancer Drugs in R&d Clear-Out
24 Jul 2025 //
FIERCE BIOTECH
Zealand Pharma Appoints Eric Cox as Chief Commercial Officer
29 Jul 2024 //
GLOBENEWSWIRE
Fractyl Health files for IPO to back gene therapy
14 Dec 2023 //
ENDPTS
Obesity and diabetes biotech Carmot Therapeutics files for IPO
17 Nov 2023 //
ENDPTS

Market Place
Sourcing Support